Fmr LLC Has $122,000 Stock Holdings in SIGA Technologies, Inc. (NASDAQ:SIGA)

Fmr LLC lessened its stake in SIGA Technologies, Inc. (NASDAQ:SIGA) by 53.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,076 shares of the company’s stock after selling 20,702 shares during the quarter. Fmr LLC’s holdings in SIGA Technologies were worth $122,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. American Century Companies Inc. increased its holdings in SIGA Technologies by 251.2% in the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock valued at $6,389,000 after purchasing an additional 602,091 shares during the last quarter. Foundry Partners LLC bought a new position in shares of SIGA Technologies in the third quarter valued at $2,801,000. Denali Advisors LLC acquired a new position in SIGA Technologies during the second quarter worth $1,815,000. Harbor Capital Advisors Inc. bought a new position in SIGA Technologies during the third quarter worth about $1,098,000. Finally, WINTON GROUP Ltd acquired a new stake in SIGA Technologies during the 2nd quarter valued at $1,052,000. Institutional investors own 55.40% of the company’s stock.

SIGA Technologies Stock Down 2.0 %

SIGA Technologies stock opened at $5.91 on Monday. The stock has a market cap of $422.00 million, a P/E ratio of 4.93 and a beta of 0.89. The company’s 50-day moving average price is $6.76 and its two-hundred day moving average price is $7.73. SIGA Technologies, Inc. has a twelve month low of $4.26 and a twelve month high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The company had revenue of $10.01 million during the quarter. Equities analysts anticipate that SIGA Technologies, Inc. will post 1.04 earnings per share for the current fiscal year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.